Carboxamides, reduction

H-Chromene, 2-ethyl-3-phenyl-synthesis, 3, 764 4H-Chromene, 2-phenyl-synthesis, 3, 763 4H-Chromene, 2,4,4-trimethyl-addition reactions, 3, 669 2 H-Chromene-3-carboxamide reduction, 3, 675 2H-Chromene-3-carboxylic acid methyl ester alcoholysis, 3, 668... 

Indole-7-carbaldehyde, 1-methyl-synthesis, 4, 83 Indole-3-carbaldehydes synthesis, 2, 251 Indole-2-carboxamide reduction, 4, 256 synthesis, 4, 360 Indole-3-carboxamide synthesis, 4, 347... 

For example, interaction of 3-ethoxycarbonylmethylquinuclidine-2-carb-oxylic acid (XX) with thionyl chloride readily gave an acylchloride which by reaction with primary and secondary amines can be converted to 3-ethoxy-carbonylmethyl-quinuclidine-2-carboxamides. Reduction of these amidoesters with lithium aluminiumhydride afforded 3-(j8-hydroxyethyl)-2-alkyl(dialkyl)-aminomethylquinuclidines [91, 97]. 

H-Dibenz[6,/]azepine-5-carboxamide pharmacological properties, 7, 546 Dibenz[6,e]azepine-6,11-dione, 10-amino-reactions, 7, 526 Dibenz[6,e]azepinediones intramolecular nucleophilic substitution, 7, 516 synthesis, 7, 531 Dibenz[6,e]azepine-5,11-diones epoxides, 7, 515 reduction, 7, 525... 

Imidazole-5-carboxamide, 4-cyano-reduction, 5, 435 synthesis, 5, 461, 472 Imidazole-5-carboxamide, 4-mercapto-oxidation, 5, 445... 

Other methods for the preparation of cyclohexanecarboxaldehyde include the catalytic hydrogenation of 3-cyclohexene-1-carboxaldehyde, available from the Diels-Alder reaction of butadiene and acrolein, the reduction of cyclohexanecarbonyl chloride by lithium tri-tcrt-butoxy-aluminum hydride,the reduction of iV,A -dimethylcyclohexane-carboxamide with lithium diethoxyaluminum hydride, and the oxidation of the methane-sulfonate of cyclohexylmethanol with dimethyl sulfoxide. The hydrolysis, with simultaneous decarboxylation and rearrangement, of glycidic esters derived from cyclohexanone gives cyclohexanecarboxaldehyde. 

The complex thioamide lolrestat (8) is an inhibitor of aldose reductase. This enzyme catalyzes the reduction of glucose to sorbitol. The enzyme is not very active, but in diabetic individuals where blood glucose levels can. spike to quite high levels in tissues where insulin is not required for glucose uptake (nerve, kidney, retina and lens) sorbitol is formed by the action of aldose reductase and contributes to diabetic complications very prominent among which are eye problems (diabetic retinopathy). Tolrestat is intended for oral administration to prevent this. One of its syntheses proceeds by conversion of 6-methoxy-5-(trifluoroniethyl)naphthalene-l-carboxyl-ic acid (6) to its acid chloride followed by carboxamide formation (7) with methyl N-methyl sarcosinate. Reaction of amide 7 with phosphorous pentasulfide produces the methyl ester thioamide which, on treatment with KOH, hydrolyzes to tolrestat (8) 2[. 

In 2009, Beller (Scheme 45) [147] and Nagashima (Scheme 46) [148] independently reported an iron-catalyzed hydrosilane reduction of carboxamides to amines. Although inexpensive PMHS and TMDS as an H-Si source are usable, the yield of product considerably decreased when hydrosilane containing only one H-Si moiety or iron sources such as Fe(acac)2 and FeX2 (X = F, Cl) was used. In both thermal and photoassisted conditions, almost the same reactivities were observed upon using a combination of Fe catalyst with TMDS (Scheme 46). 

Reduction of 3-benzyl-8-chloro-4-oxo-4//-pyrido[l,2- ]pyrimidine-2-carboxylate <2004W004/064741> and 2-methyl-4-oxo-4//-pyrido[l,2-tf]pyrimidine-3-carboxylate <2003T4123> with DIBAL-H afforded 2- and 3-formyl derivatives, respectively. Reduction of /V-(4-fluorobenzyl)-3-hydroxy-8-[methoxy(methyl)amino]-4-oxo-6,7,8,9-tetra-hydro-4//-pyrido[l,2- ]pyrimidine-2-carboxamide with Zn-dust in aqueous AcOH afforded the 8-methylamino derivative, which was acylated with AcOH in the presence of Hiinig s base, HOBt, and l-(3-dimethylaminopro-pyl)-3-ethylcarbodiimide-HCl <2004W004/058756>. 3-(Perhydropyrido[l,2- ]pyrimidin-2-yl)propylamine was obtained by catalytic hydrogenation of 2-(perhydropyrido[l,2- ]pyrimidin-2-yl)propionitrile over a Pt02 catalyst <2003FRP1275647>. 

An interesting example of asymmetric induction has been used for the synthesis of (—)-l from L-tryptophan. Pictet-Spengler cyclization of the corresponding amide (127) with 5-chloropentanal afforded (—)-128 as the sole product. Removal of the unwanted carboxamide function was achieved in good yield by sodium borohydride reduction of die corresponding a-amino nitrile (—)-129, resulting in (—)-l (98). 

The catalysed two-phase alkylation of carboxamides has the advantages of speed and simplicity over the traditional procedures and provides a valuable route to secondary and tertiary amines by hydrolysis or reduction of the amides, respectively. The procedure appears to be limited, however, to reactions with primary haloalkanes and dialkyl sulphates, as secondary haloalkanes are totally unreactive [6, 7]. The use of iodoalkanes should be avoided, on account of the inhibiting effect of the released iodide ion on the catalyst. Also, the A-alkylation reaction is generally susceptible to steric effects, as seen by the low yields in the A -cthylation of (V-/-butylacetamide and of A-ethylpivalamide [6]. However, the low steric demand of the formyl group permits A,A-dialkylation and it is possible to obtain, after hydrolysis in 60% ethanolic sulphuric acid, the secondary amines having one (or, in some cases, two) bulky substituent(s) [7]. 

---